{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T03:42:14Z","timestamp":1794886934081,"version":"4.9.1"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2007,1,15]],"date-time":"2007-01-15T00:00:00Z","timestamp":1168819200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Headache"],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:p>Objective.\u2014The aim was to assess the timing and severity of self\u2010reported headaches in patients utilizing a standard 28\u2010day oral contraceptive (OC) cycle consisting of 21 hormone (estrogen + progestin)\u2010containing pills and 7 placebo pills (ie, 21\/7\u2010day cycle) converted to a placebo\u2010free extended OC regimen.<\/jats:p>\n                  <jats:p>Methods.\u2014An open label single\u2010center prospective analysis of headaches recorded daily on a severity scale of 0 to 10, along with the headache item of the Penn Daily Symptom Rating (DSR17) and a weekly modified Migraine Disability Assessment (MIDAS) headache questionnaire, during standard 21\/7\u2010day cycles followed by a 168\u2010day extended placebo\u2010free regimen of an OC containing 3 mg of drosperinone and 30 mcg of ethinyl estradiol (DRSP\/EE).<\/jats:p>\n                  <jats:p>\n                    Results.\u2014Of the 114 patients who began the trial, 111 completed the 21\/7\u2010day cycle portion of the study. Based on the headaches scales, there were significant differences in headache severity among the 28 days of the standard 21\/7 cycles (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .001). Greater headache severity occurred on days 25 through 28 during the 7\u2010day placebo interval of the 21\/7 cycles (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .05). Of the 111 patients who completed the 21\/7 phase of the study, 102 (92%) completed the 168\u2010day extended placebo\u2010free OC regimen. During the first 28 days of the extended placebo\u2010free regimen, daily headache scores decreased (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .0001) compared to those of the previous 21 active\/7 placebo day cycle. The difference on a daily basis was first detected on extended cycle days 25 through 28 (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .0001) and persisted throughout the remainder of the 168\u2010day regimen. Subjects were divided into 2 groups (severe and mild) based on the median of the total headache score during the 21\/7 OC cycle. The group with higher total headache scores demonstrated a significant (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .0001) reduction in daily headaches beginning in the first 28\u2010day interval of the extended placebo\u2010free regimen, persisting throughout the entire 168\u2010day extended regimen. In contrast, the group with the lower total headache score remained unchanged (\n                    <jats:italic>P<\/jats:italic>\n                    = .79) throughout the extended regimen. Impact of headaches on work, family, and social functions also improved on the extended placebo\u2010free regimen in 6 of 8 measures (\n                    <jats:italic>P<\/jats:italic>\n                    &lt; .05) assessed by weekly headache questionnaires.\n                  <\/jats:p>\n                  <jats:p>Conclusion.\u2014Compared to a 21\/7\u2010day OC regimen, a 168\u2010day extended placebo\u2010free regimen of DRSP\/EE led to a decrease in headache severity along with improvement in work productivity and involvement in activities. This is a preliminary study and results may not be widely generalizable.<\/jats:p>","DOI":"10.1111\/j.1526-4610.2007.00650.x","type":"journal-article","created":{"date-parts":[[2007,1,16]],"date-time":"2007-01-16T05:29:52Z","timestamp":1168925392000},"page":"27-37","source":"Crossref","is-referenced-by-count":131,"title":["Headaches and Oral Contraceptives: Impact of Eliminating the Standard 7\u2010Day Placebo Interval"],"prefix":"10.1111","volume":"47","author":[{"given":"Patricia","family":"Sulak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherilyn","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Kuehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Coffee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,1,15]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(98)70047-X"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(99)00027-X"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2001.041007638.x"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000133134.68143.2E"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.2003.00516.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.22.4.355"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1990.1003147.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra000471"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(99)00524-4"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.12.089"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000175834.77215.2e"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(00)00133-5"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1185\/03007998709112403"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349509021201"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/13625180008500387"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2004.07.010"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(03)00141-0"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(02)00445-6"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200304000-00008"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2002.122988"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2004.04.007"},{"key":"e_1_2_8_23_2","first-page":"CD004695","article-title":"Continuous or extended cycle vs cyclic use of combined oral contraceptives for contraception","author":"Edelman AB","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.02.048"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2006.05.012"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2003.03050.x"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.2002.02230.x"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-2982.2000.00112.x"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4610.1990.hed3004224.x"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-4610.1999.3909674.x"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(96)00488-7"}],"container-title":["Headache: The Journal of Head and Face Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1526-4610.2007.00650.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1526-4610.2007.00650.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:45:29Z","timestamp":1762083929000},"score":1,"resource":{"primary":{"URL":"https:\/\/headachejournal.onlinelibrary.wiley.com\/doi\/10.1111\/j.1526-4610.2007.00650.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.1111\/j.1526-4610.2007.00650.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1526-4610.2007.00650.x","archive":["Portico"],"relation":{},"ISSN":["0017-8748","1526-4610"],"issn-type":[{"value":"0017-8748","type":"print"},{"value":"1526-4610","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}